Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.6K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

11.8K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.8K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

4.1K
No description available
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pluripotent stem cell lines available for use in clinical applications: A comprehensive overview.

Stem cell reports·2026
Same author

Charting the translational pathway: ISSCR best practices for the development of PSC-derived therapies.

Stem cell reports·2026
Same author

Pluripotent stem cell lines available for use in clinical applications: A comprehensive overview.

Stem cell reports·2025
Same author

The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?

Stem cell reports·2018
Same author

2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.

Stem cells translational medicine·2015
Same author

Cell Therapy Regulatory Toolkit: an online regulatory resource.

Regenerative medicine·2015

Related Experiment Video

Updated: Jan 31, 2026

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.4K

Regulatory considerations for pluripotent stem cell therapies.

Melissa K Carpenter1

  • 1Carpenter Group Consulting, Seattle, WA, United States.

Progress in Brain Research
|May 30, 2017
PubMed
Summary

Developing pluripotent stem cell (PSC) therapies faces regulatory hurdles. This review outlines US regulations and compliance strategies for PSC-derived products in clinical trials.

Keywords:
Donor eligibilityFDAGMPGTPPluripotent stem cellRegulatory

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.2K
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Related Experiment Videos

Last Updated: Jan 31, 2026

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation
06:55

Transient Treatment of Human Pluripotent Stem Cells with DMSO to Promote Differentiation

Published on: July 17, 2019

15.4K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.2K
Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells
10:24

Transfecting and Nucleofecting Human Induced Pluripotent Stem Cells

Published on: October 5, 2011

22.0K

Area of Science:

  • Stem cell biology
  • Regulatory science
  • Biotechnology

Background:

  • Pluripotent stem cell (PSC) therapies are advancing rapidly, with many products in clinical trials.
  • The complexity of PSC-derived products presents unique regulatory challenges.
  • Compliance requires careful consideration of starting materials, manufacturing consistency, and preclinical assessments.

Purpose of the Study:

  • To review current US cell therapy regulations relevant to PSC-derived products.
  • To discuss strategies for navigating regulatory compliance during PSC therapy development.

Main Methods:

  • Literature review of US cell therapy regulations.
  • Analysis of regulatory requirements for cell product development.
  • Discussion of compliance strategies for PSC-derived therapies.

Main Results:

  • Identified key regulatory considerations for PSC-derived products, including starting material selection, manufacturing, and preclinical testing.
  • Outlined current US regulatory frameworks governing cell therapies.
  • Provided actionable strategies for developers to ensure compliance.

Conclusions:

  • Navigating regulatory pathways is crucial for the successful clinical translation of PSC therapies.
  • Proactive engagement with regulatory guidelines and strategic planning can facilitate the development of safe and effective PSC-derived products.